English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, June 25, 2024
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Tuesday, June 18, 2024
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Tuesday, April 23, 2024
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Monday, April 1, 2024
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Thursday, March 28, 2024
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575